Adma Biologics Inc’s filing revealed that its President and CEO Grossman Adam S unloaded Company’s shares for reported $0.4 million on Mar 19 ’25. In the deal valued at $18.92 per share,21,000 shares were sold. As a result of this transaction, Grossman Adam S now holds 2,061,850 shares worth roughly $40.04 million.
Then, Grossman Adam S bought 84,000 shares, generating $1,571,640 in total proceeds.
Before that, Tade Brad L. sold 15,000 shares. Adma Biologics Inc shares valued at $317,250 were divested by the CFO and Treasurer at a price of $21.15 per share. As a result of the transaction, Tade Brad L. now holds 199,433 shares, worth roughly $3.87 million.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Tuesday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock fall -2.12% to $19.42. Over the last five days, the stock has lost -3.96%. Adma Biologics Inc shares have risen nearly 13.24% since the year began. Nevertheless, the stocks have risen 194.24% over the past one year. While a 52-week high of $23.64 was reached on 03/25/25, a 52-week low of $5.89 was recorded on 03/04/25. SMA at 50 days reached $17.28, while 200 days put it at $16.88.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 19.07, which if violated will result in even more drops to 18.73. On the upside, there is a resistance level at 19.84. A further resistance level may holdings at 20.26. The Relative Strength Index (RSI) on the 14-day chart is 56.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.76%. Stochastics %K at 73.22% indicates the stock is a holding.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2025-03-14, growing by 1.33 million shares to a total of 15.07 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 13.74 million shares. There was a rise of 8.83%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
